💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

U.S. asks judge to give final approval to settlement with CVS to buy Aetna

Published 02/25/2019, 04:01 PM
Updated 02/25/2019, 04:05 PM
© Reuters. Logos of CVS and Aetna are displayed on a monitor above the floor of the New York Stock Exchange shortly after the opening bell in New York
AET
-
CVS
-

WASHINGTON (Reuters) - The U.S. Justice Department formally asked a judge on Monday to approve its deal to allow CVS Health Corp (NYSE:CVS) to merge with insurer Aetna (NYSE:AET).

Judge Richard Leon of the U.S. District Court for the District of Columbia scolded the government and parties late last year for closing the $69 billion dollar merger before the consent order was approved by the court. In response, CVS offered to halt some integration of the two companies.

With the government's request for final approval of the merger, Leon may sign off on the deal with no further ado or may decide to hold a hearing to allow critics to raise their concerns, said Andre Barlow of the law firm Doyle, Barlow and Mazard PLLC, an antitrust expert who has been following the case.

The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc. Both deals have closed.

© Reuters. Logos of CVS and Aetna are displayed on a monitor above the floor of the New York Stock Exchange shortly after the opening bell in New York

CVS declined comment for this story.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.